Epsito Tablet 10 mg (Fexuprazan Hydrochloride)

Adult dose

This medicine is administered to adults as follows. 1. Treatment of erosive gastroesophageal reflux disease - Take 40 mg orally once daily for 4 weeks. - In patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 2. Improvement of gastric mucosal lesions in acute and chronic gastritis <10 mg only> - Take 10 mg orally twice daily for 2 weeks. This medicine may be taken with or without food.

This medication should not be used in certain patients. Patients with allergies or hypersensitivity to this medication or its components should not take it. Additionally, patients taking specific antivirals (atazanavir, nelaminavir, rilpivirine) should also avoid using this medication. It is safer for pregnant or breastfeeding women not to take this medication. As this medication contains lactose, patients with lactose intolerance or related genetic conditions should not use it. Care should be taken when administering this medication to patients with liver or kidney function problems due to a lack of experience. Elderly patients or those with a history of allergies to specific colorants included in this medication (Yellow No. 4, Yellow No. 5) should be particularly cautious. Adverse reactions such as dyspepsia, diarrhea, headache, and skin rash may occur while taking this medication. Most adverse reactions are mild, but if symptoms persist or worsen, medical consultation is necessary. This medication may suppress gastric acid secretion and slightly increase the risk of bacterial infection in the stomach; therefore, if diarrhea symptoms do not improve, further testing may be required. Additionally, the risk of fractures related to osteoporosis may increase with long-term use, so monitoring of bone health may be necessary if required. Long-term use of more than 3 months may lower serum magnesium levels, so regular blood tests are recommended. Vitamin B12 deficiency may also occur, so testing should be done if related symptoms arise. This medication changes the pH in the stomach and may affect the absorption of other medications, so care should be taken with potential interactions with concurrent medications. Pregnant or breastfeeding women are advised against using this medication, and in the case of breastfeeding, it is recommended to discontinue breastfeeding. Safety and efficacy in children and adolescents have not been sufficiently established, so caution is required for use. Elderly individuals may be more affected by the medication due to declines in liver and kidney function, so consultation with medical personnel before taking the medication is necessary. No specific toxic symptoms have been reported in case of overdose, but if symptoms appear, it is important to visit a healthcare facility immediately for appropriate treatment. This medication should be stored out of the reach of children and should not be transferred to other containers.

• Dyspepsia
• diarrhea
• nausea
• abdominal discomfort
• chronic gastritis
• gastritis
• erosive gastritis
• erythema
• pruritus
• headache

This medication may be sensitive to air or moisture and should be stored in a tightly sealed container. It is preferable to maintain storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage helps ensure the safety of the medication's effectiveness.

Appearance

Orange rectangular film-coated tablet

Package unit

28 tablets/box [7 tablets/PTP*4], 28 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle